Proteoz 2 mg Injection
  1. Home
  2. Pharma Products
  3. Cadila Healthcare Ltd
  4. Proteoz 2 mg Injection

Proteoz 2 mg Injection

Proteoz 2 mg Injection contains bortezomib, a proteasome inhibitor used mainly to treat multiple myeloma and mantle cell lymphoma. It is supplied as a 2 mg injection and is administered by a qualified healthcare professional. Bortezomib blocks proteasome activity, causing cancer cells to accumulate damaged proteins and eventually die.

BUY NOW

Category

Proteoz 2 mg Injection works by interfering with the protein-processing system that cancer cells depend on for survival and growth. This action helps reduce the multiplication and survival of abnormal plasma cells and lymphoma cells. It may be administered intravenously or subcutaneously according to the prescribed treatment protocol. Patients require medical monitoring during therapy, including assessment of blood counts and possible treatment-related adverse effects.

Technical Specification

Specification Details
Active Ingredient Bortezomib
Strength 2 mg
Dosage Form Injection
Route of Administration Intravenous / Subcutaneous
Pack Size 1 Vial
Manufacturer/Marketer Zydus Healthcare Ltd

Product Also Known As

Proteoz 2 mg Injection, Proteoz 2mg Injection, Proteoz Bortezomib Injection, Bortezomib 2 mg Injection, Bortezomib Cancer Injection, Bortezomib Multiple Myeloma Injection